Clinical course and management of insidious adrenal crisis manifested initially as hyperpyrexia secondary to pembrolizumab: Case reports and literature review

Immune checkpoint inhibitors (ICIs) are novel drugs with a dramatic survival benefit in patients with advanced malignancies. With the widespread use, several immune-related adverse events (irAEs) have emerged, which may be life-threatening. Herein we report two patients with adrenal crisis who recei...

Descripción completa

Detalles Bibliográficos
Autores principales: Geng, Dandan, Wang, Yingnan, Zhang, Xin, Zhao, Chenguang, Fan, Yao, Liu, Chang, Wei, Jinmei, Huo, Bingjie, Zhao, Yang, Zhang, Fengbin, Zhang, Ruixing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403738/
https://www.ncbi.nlm.nih.gov/pubmed/36033475
http://dx.doi.org/10.3389/fonc.2022.981084

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403738/
https://www.ncbi.nlm.nih.gov/pubmed/36033475
http://dx.doi.org/10.3389/fonc.2022.981084

Ejemplares similares